01 March 2004
Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthmaLászló Virág, Peter Bai, István Bak, Pal Pacher, Jon Mabley, Lucas Liaudet, Edina Bakondi, Pal Gergely, Mark Kollai, Csaba Szabo
Med Sci Monit 2004; 10(3): BR77-83 :: ID: 11613
Background:Poly(ADP-ribose) polymerase-1 (PARP-1), a monomeric nuclear enzyme present in eukaryotes, plays a role in cell death, inflammatory mediator expression, and mononuclear cell recruitment in various experimental models of inflammation and reperfusion injury. Part of the molecular mechanism of this function involves the regulation of cytokine and chemokine production. Since chemokines are principal regulators of mononuclear and polymorphonuclear cell trafficking in asthma, we investigated the possibility whether PARP modulates chemokine production and cell recruitment in a murine model of asthma.Material/Methods: We studied ovalbumin-sensitized mice challenged with a single dose of ovalbumin.Results: PARP inhibition with the phenanthridinone-based PARP inhibitor PJ34 suppressed inflammatory cell migration. These effects were associated with downregulation of the CC chemokine MIP-1alpha, but not the CXC chemokine MIP-2. The production of TNF- alpha and IL-12, but not IL-5 or IL-13, was also suppressed by PARP inhibition.Conclusions: Our results demonstrate the pathogenetic role of PARP activation in a murine model of asthma. PARP selectively regulates the production of certain chemokines and cytokines in this experimental model, which may be responsible for some of the observed protective effects seen in the current murine asthma model.
Keywords: Asthma - drug therapy, Bronchoalveolar Lavage, Catalysis, Cell Death, Chemokines - metabolism, Cytokines - metabolism, Enzyme Inhibitors - pharmacology, Interleukin-10 - metabolism, Interleukin-12 - metabolism, Interleukin-13 - metabolism, Interleukin-5 - metabolism, Leukocytes, Mononuclear - metabolism, Lung - pathology, Mice, Inbred BALB C, Ovalbumin - metabolism, Ovalbumin - pharmacology, Peroxidase - metabolism, Poly(ADP-ribose) Polymerases - antagonists & inhibitors, Time Factors, Tumor Necrosis Factor-alpha - metabolism, Asthma - drug therapy, Bronchoalveolar Lavage, Catalysis, Cell Death, Chemokine CXCL2, Chemokines - metabolism, Cytokines - metabolism, Enzyme Inhibitors - pharmacology, Interleukin-10 - metabolism, Interleukin-12 - metabolism, Interleukin-13 - metabolism, Interleukin-5 - metabolism, Leukocytes, Mononuclear - metabolism, Lung - pathology, Mice, Inbred BALB C, Ovalbumin - pharmacology, Peroxidase - metabolism, Poly(ADP-ribose) Polymerases - antagonists & inhibitors, Time Factors, Tumor Necrosis Factor-alpha - metabolism
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952